mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.4 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |